Mitoxantrone for carcinoma of the endometrium: a phase II trial of the Gynecologic Oncology Group.
D000328:Adult; D000368:Aged; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008875:Middle Aged; D008942:Mitoxantrone / Q000009:adverse effects / Q000627:therapeutic use*; D009362:Neoplasm Metastasis; D014594:Uterine Neoplasms / Q000188:drug therapy*
D008942:Mitoxantrone